Mimedx (MDXG) Interest Expenses (2011 - 2015)
Mimedx's (MDXG) quarterly Interest Expenses came in at $14000.0 in Q1 2015, down 33.33% year-on-year from $21000.0 in Q1 2014, and up 48.6% quarter-over-quarter from $9421.0 in Q4 2014.
Mimedx (MDXG) Interest Expenses (2011 - 2015) Analysis & Trends
Mimedx has disclosed Interest Expenses across 5 years of filings, most recently posting $14000.0 for Q1 2015.
- Interest Expenses for Q1 2015 came in at $14000.0, down 33.33% year-over-year; the trailing twelve-month figure through Dec 2015 was $14000.0 (down 70.82% YoY), and the FY2016 annual result was $339000.0, up 294.19% from the prior year.
- Interest Expenses came in at $14000.0 for Q1 2015 at Mimedx, up from $9421.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $153804.0 in Q2 2012 to a low of $4527.0 in Q3 2013.
- The 5-year median for Interest Expenses is $21000.0 (2014), against an average of $57226.6.
- Across the five-year window, Interest Expenses soared 251.23% in 2012 and slumped 96.89% in 2013, its largest moves.
- Mimedx's Interest Expenses stood at $40373.0 in 2011, then jumped by 251.23% to $141804.0 in 2012, then slumped by 91.19% to $12497.0 in 2013, then declined by 24.61% to $9421.0 in 2014, then soared by 48.6% to $14000.0 in 2015.
- The last three Interest Expenses figures came in at $14000.0 (Q1 2015), $9421.0 (Q4 2014), and $9126.0 (Q3 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 14,000.00 |
| Mar 31, 2015 | 14,000.00 |
| Dec 31, 2014 | 9,421.00 |
| Dec 31, 2014 | 9,421.00 |
| Sep 30, 2014 | 9,126.00 |
| Sep 30, 2014 | 9,126.00 |
| Jun 30, 2014 | 8,429.00 |
| Jun 30, 2014 | 8,429.00 |
| Mar 31, 2014 | 21,000.00 |
| Mar 31, 2014 | 21,000.00 |
| Dec 31, 2013 | 12,497.00 |
| Dec 31, 2013 | 12,497.00 |
| Sep 30, 2013 | 4,527.00 |
| Sep 30, 2013 | 4,527.00 |
| Jun 30, 2013 | 13,172.00 |
| Jun 30, 2013 | 13,172.00 |
| Mar 31, 2013 | 14,804.00 |
| Mar 31, 2013 | 14,804.00 |
| Dec 31, 2012 | 141,804.00 |
| Dec 31, 2012 | 141,804.00 |